Are you an EPFL student looking for a semester project?
Work with us on data science and visualisation projects, and deploy your project as an app on top of Graph Search.
ND Biosciences is a spinoff from the Swiss Federal Institute of Technology in Lausanne (EPFL), dedicated to developing next-generation therapeutics for neurodegenerative diseases (NDs) such as Parkinson's and Alzheimer's Disease. Leveraging over 15 years of research, ND Biosciences has created an integrated suite of novel, validated, and patented drug-discovery platforms. These platforms accurately replicate the diversity, structural, and biochemical properties of pathogenic protein aggregates observed in patient brains, enabling more precise antigen generation for drug development. By utilizing cellular models that mimic different stages of protein aggregation, including early and terminal stages leading to neurodegeneration, ND Biosciences can assess efficacy and identify next-generation hits using translationally-relevant models.
Hilal Lashuel, Galina Limorenko